IKT
Inhibikase Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$2.00
+0.01 ▲ +0.50%
🌙 3월 13일 7:53 PM ET (한국 3/14 08:53)
$1.98
-0.02 ▼ -1.00%
| Index | RUT | P/E | - | EPS (ttm) | -0.57 | Insider Own | 24.56% | Shs Outstand | 0.12B | Perf Week | 6.38% |
| Market Cap | 0.24B | Forward P/E | - | EPS next Y | 2.37% | Insider Trans | 7.47% | Shs Float | 0.09B | Perf Month | 16.96% |
| Enterprise Value | 0.17B | PEG | - | EPS next Q | -0.1 | Inst Own | 70.77% | Short Float | 17.54% | Perf Quarter | 35.14% |
| Income | -0.05B | P/S | - | EPS this Y | 56.92% | Inst Trans | 53.4% | Short Ratio | 9.99 | Perf Half Y | 19.05% |
| Sales | 0.00B | P/B | 2.05 | EPS next 5Y | 22.9% | ROA | -113.51% | Short Interest | 16.04M | Perf YTD | -2.44% |
| Book/sh | 0.97 | P/C | 3.14 | EPS past 3/5Y | 38.01% 18.99% | ROE | -131.71% | 52W High | -22.48% ($2.58) | Perf Year | -9.09% |
| Cash/sh | 0.64 | P/FCF | - | Sales past 3/5Y | - | ROIC | -65.37% | 52W Low | 50.38% ($1.33) | Perf 3Y | -55.27% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 79.01% | Gross Margin | - | Volatility(W/M) | 6.37% 7.49% | Perf 5Y | -94.77% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | -100% | Oper. Margin | - | ATR (14) | 0.14 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 11.67 | EPS Q/Q | 79.63% | Profit Margin | - | RSI (14) | 59.19 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 11.67 | Sales Q/Q | - | SMA20 | 4.71% ($1.91) | Beta | 0.8 | Target Price | $5.75 |
| Payout | - | Debt/Eq | 0 | Earnings | 11000000 | SMA50 | 11.83% ($1.79) | Rel Volume | 0.73 | Prev Close | $1.99 |
| Employees | 16 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | 16.58% ($1.72) | Avg Volume(3M) | 1.61M | Price | $2 |
| IPO | 2020/12/23 | Option/Short | No/Yes | Trades | 5465 | Volume | 1,170,561 | Change | 0.5% |
뉴스 로딩 중...